<p><i>x</i>-Axis indicates interval between start of induction and maintenance therapies, in days. Maintenance therapy is assumed to start on day 0. <i>y</i>-Axis indicates percentage of simulations in which viral load remained undetectable for at least 3 y after ending induction therapy. Interpretation: the success of IM therapy increases with increasing duration of induction therapy. Delaying the start of induction therapy until ∼40 d after the start of maintenance therapy may be optimal, and the effect of timing is most pronounced with induction therapies lasting 0.5–2 mo. Longer and shorter induction periods are less sensitive to the effects of timing. There is little benefit to adding a delayed-induction therapy at times beyond 90 d af...
<p>When therapy significantly blocks both intracellular viral production () and assembly/secretion (...
Analysis of number of days from antiretroviral therapy initiation to achieving suppressed viral load...
<p>(A) Duration of initial intensive phase in all patients (reference group 1.0–2.5 mo). (B) Duratio...
<div><p>(A) Effect of progressively longer induction regimens (circles A–C) on the likelihood of suc...
<div><p>(A,B) Effects of fitness (<i>w</i>) of resistant viruses in the absence of drug.</p><p>(C,D)...
<p>As in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.0030133#pcbi-003...
<p>As in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.0030133#pcbi-003...
<div><p>(A,B) Effect of proportion of infected cells becoming latently infected quiescent memory T l...
A. Example of viral load trajectories for animals treated on days 4 (blue), 6 (green), 27 (red) from...
A. Example of viral load trajectories for animals treated on days 4 (blue), 6 (green), 27 (red) from...
The time of initiation of antiretroviral therapy in HIV-1 infected patients has a determinant effect...
<p>Δ<sub>1</sub> represents the initial treatment effect at the end of the placebo-controlled period...
<p>Panels A and B show the effect of timing of injections when the dose of injections is fixed. Pane...
Abstract Background Induction-maintenance therapy is ...
<p>(<b>A</b>) Schematic representation of the modeled surgery time point followed by intravesical tr...
<p>When therapy significantly blocks both intracellular viral production () and assembly/secretion (...
Analysis of number of days from antiretroviral therapy initiation to achieving suppressed viral load...
<p>(A) Duration of initial intensive phase in all patients (reference group 1.0–2.5 mo). (B) Duratio...
<div><p>(A) Effect of progressively longer induction regimens (circles A–C) on the likelihood of suc...
<div><p>(A,B) Effects of fitness (<i>w</i>) of resistant viruses in the absence of drug.</p><p>(C,D)...
<p>As in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.0030133#pcbi-003...
<p>As in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.0030133#pcbi-003...
<div><p>(A,B) Effect of proportion of infected cells becoming latently infected quiescent memory T l...
A. Example of viral load trajectories for animals treated on days 4 (blue), 6 (green), 27 (red) from...
A. Example of viral load trajectories for animals treated on days 4 (blue), 6 (green), 27 (red) from...
The time of initiation of antiretroviral therapy in HIV-1 infected patients has a determinant effect...
<p>Δ<sub>1</sub> represents the initial treatment effect at the end of the placebo-controlled period...
<p>Panels A and B show the effect of timing of injections when the dose of injections is fixed. Pane...
Abstract Background Induction-maintenance therapy is ...
<p>(<b>A</b>) Schematic representation of the modeled surgery time point followed by intravesical tr...
<p>When therapy significantly blocks both intracellular viral production () and assembly/secretion (...
Analysis of number of days from antiretroviral therapy initiation to achieving suppressed viral load...
<p>(A) Duration of initial intensive phase in all patients (reference group 1.0–2.5 mo). (B) Duratio...